Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-16 · accession 0001415889-25-013673 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-19 | 2025-05-16+ | FENC | Hackman Jeffrey S. | CEO, Dir | P - Purchase | $6.97 | +15.0K | 15.0K | New | +$104.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-05-16 | P | A | 1,035 | $6.75 | 1,035 | D | — | — | (F1) Transaction Code P - Open market or private purchase of non-derivative or derivative security |
| 2 | Common | Common Shares | 2025-05-19 | P | A | 13,965 | $6.99 | 15,000 | D | — | — | (F1) Transaction Code P - Open market or private purchase of non-derivative or derivative security |